Our round-up of recent biotech financings is headed by a sizeable $200 million third round for Zenas BioPharma, with Cellectis, Reunion Neuroscience, Karius, Context Therapeutics, and Enlaza also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback